Michaela Glenck - Merck KGaA Member of the Supervisory Board

MKKGY Stock  USD 32.44  0.46  1.40%   

Executive

Ms. Michaela Freifrau von Glenck is Member of the Supervisory Board at Merck KGaA. She is Teacher by profession.
Phone49 6151 72 0
Webhttps://www.merckgroup.com

Merck KGaA Management Efficiency

The company has return on total asset (ROA) of 0.0656 % which means that it generated a profit of $0.0656 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1422 %, meaning that it generated $0.1422 on every $100 dollars invested by stockholders. Merck KGaA's management efficiency ratios could be used to measure how well Merck KGaA manages its routine affairs as well as how well it operates its assets and liabilities.
The company has accumulated 7.93 B in total debt with debt to equity ratio (D/E) of 0.45, which is about average as compared to similar companies. Merck KGaA ADR has a current ratio of 1.25, suggesting that it may not be capable to disburse its financial obligations in time and when they become due. Debt can assist Merck KGaA until it has trouble settling it off, either with new capital or with free cash flow. So, Merck KGaA's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Merck KGaA ADR sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Merck to invest in growth at high rates of return. When we think about Merck KGaA's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

EXECUTIVE Age

Iris LoewFriedrichFresenius SE Co
57
Dietmar OeterMERCK Kommanditgesellschaft auf
51
Constantin BirnstielMERCK Kommanditgesellschaft auf
N/A
Takashi KuzuharaRecruit Holdings Co
N/A
Rice PowellFresenius SE Co
63
Gregor SchulzMERCK Kommanditgesellschaft auf
67
Ayano SenahaRecruit Holdings Co
41
KarlHeinz ScheiderMERCK Kommanditgesellschaft auf
N/A
Suguru TomizukaRecruit Holdings Co
51
Hiroaki OgataRecruit Holdings Co
N/A
Hisayuki IdekobaRecruit Holdings Co
48
Akihiko OkamotoRecruit Holdings Co
N/A
Wolfgang BeckerStraumann Holding AG
57
Petra RumpfStraumann Holding AG
51
Mike RynersonStraumann Holding AG
47
Michael DiekmannFresenius SE Co
63
KlausPeter MuellerFresenius SE Co
73
Michael KleinemeierMERCK Kommanditgesellschaft auf
61
Belen GarijoMERCK Kommanditgesellschaft auf
57
Helga RuebsamenSchaeffMERCK Kommanditgesellschaft auf
69
Constantin FestMERCK Kommanditgesellschaft auf
46
MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and electronics sectors worldwide. MERCK Kommanditgesellschaft auf Aktien is a subsidiary of E. Merck Kgaa operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 62770 people. Merck KGaA ADR [MKKGY] is a Pink Sheet which is traded between brokers as part of OTC trading.

Management Performance

Merck KGaA ADR Leadership Team

Elected by the shareholders, the Merck KGaA's board of directors comprises two types of representatives: Merck KGaA inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Merck. The board's role is to monitor Merck KGaA's management team and ensure that shareholders' interests are well served. Merck KGaA's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Merck KGaA's outside directors are responsible for providing unbiased perspectives on the board's policies.
Matthias Heinzel, CEO Board
Gerhard Schmitz, Head Accounting
Stefan Oschmann, Chairman of Executive Board and CEO
Constantin Fest, Head of Investor Relations
Michaela Glenck, Member of the Supervisory Board
Veit Ulshoefer, Member of the Supervisory Board, Employee Representative
Gabriele Eismann, Member of the Supervisory Board, Employee Representative
Peter Guenter, CEO Board
Wolfgang Buechele, Chairman of the Supervisory Board
Barbara Weiland, Chief Officer
Belen MD, Chair CEO
Anke Schenkel, Head of Group Controlling & Risk Management
Marcus Kuhnert, Member of the Executive Board, CFO
Siegfried Karjetta, Member of the Supervisory Board
Alexander Putz, Member of the Supervisory Board, Employee Representative
Friederike Rotsch, Group Compliance
Dietmar Oeter, Member of the Supervisory Board, Employee Representative
Dirk Toepfer, Chief Officer
Gregor Schulz, Member of the Supervisory Board
Theo Siegert, Member of the Supervisory Board
Constantin Birnstiel, Head of Group Communications
Edeltraud Glaenzer, Member of the Supervisory Board, Employee Representative
Kai Beckmann, Chief Administrative Officer, Member of the Executive Board
Helga RuebsamenSchaeff, Member of the Supervisory Board
Udit Batra, CEO Life Science, Member of the Executive Board
Michael Fletterich, Vice Chairman of the Supervisory Board, Employee Representative
Crocifissa Attardo, Member of the Supervisory Board, Employee Representative
Albrecht Merck, Member of the Supervisory Board
Mechthild Auge, Member of the Supervisory Board, Employee Representative
Belen Garijo, CEO Healthcare, Member of the Executive Board
Walter Galinat, CEO Performance Materials, Member of the Executive Board
Tobias Thelen, Member of the Supervisory Board
Isabel Paoli, Chief Strategy Officer, Head of Communications

Merck Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Merck KGaA a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Merck KGaA in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Merck KGaA's short interest history, or implied volatility extrapolated from Merck KGaA options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Merck KGaA ADR. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.
Note that the Merck KGaA ADR information on this page should be used as a complementary analysis to other Merck KGaA's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Complementary Tools for Merck Pink Sheet analysis

When running Merck KGaA's price analysis, check to measure Merck KGaA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Merck KGaA is operating at the current time. Most of Merck KGaA's value examination focuses on studying past and present price action to predict the probability of Merck KGaA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Merck KGaA's price. Additionally, you may evaluate how the addition of Merck KGaA to your portfolios can decrease your overall portfolio volatility.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Please note, there is a significant difference between Merck KGaA's value and its price as these two are different measures arrived at by different means. Investors typically determine if Merck KGaA is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Merck KGaA's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.